{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T07:45:44Z","timestamp":1768463144285,"version":"3.49.0"},"reference-count":24,"publisher":"SPIE","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3,29]]},"DOI":"10.1117\/12.2216905","type":"proceedings-article","created":{"date-parts":[[2016,3,30]],"date-time":"2016-03-30T01:32:04Z","timestamp":1459301524000},"page":"978814","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of 6-([<sup>18<\/sup>F] fluoroacetamido)-1-hexanoic-anilide (<sup>18<\/sup>F-FAHA) as imaging probe in tumor xenograft mice model"],"prefix":"10.1117","volume":"9788","author":[{"given":"Fiona","family":"Li","sequence":"additional","affiliation":[]},{"given":"Sung Ju","family":"Cho","sequence":"additional","affiliation":[]},{"given":"Lihai","family":"Yu","sequence":"additional","affiliation":[]},{"given":"Robert H. E.","family":"Hudson","sequence":"additional","affiliation":[]},{"given":"Leonard G.","family":"Luyt","sequence":"additional","affiliation":[]},{"given":"Christopher L.","family":"Pin","sequence":"additional","affiliation":[]},{"given":"Michael S.","family":"Kovacs","sequence":"additional","affiliation":[]},{"given":"James","family":"Koropatnick","sequence":"additional","affiliation":[]},{"given":"Ting-Yim","family":"Lee","sequence":"additional","affiliation":[]}],"member":"189","reference":[{"key":"R1","first-page":"175","article-title":"Epigenetics and Disease: Pharmaceutical opportunities","author":"Atadja","year":"2011"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2010.02.030"},{"issue":"5","key":"R3","first-page":"689","article-title":"Histone modifications and cancer: biomarkers of prognosis?","volume":"2","author":"Chernova","year":"2012"},{"issue":"5","key":"R4","first-page":"39","article-title":"Histone deacetylase inhibitors: SAHA (Vorinostat). A treatment option for advanced cutaneous T-cell lymphoma","volume":"2","author":"Duvic","year":"2008"},{"key":"R5","article-title":"Epigenetics in human disease and prospects for epigenetic therapy","volume":"6990","author":"Egger","year":"2004"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2008.11.012"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3001056"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.126573"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.genom.5.061903.180014"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1111\/cge.2012.81.issue-4"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2011.100"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2009.10.011"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddi113"},{"issue":"3","key":"R14","first-page":"469","article-title":"Epigenetic therapy of cancer with histone deacetylase inhibitors","volume":"10","author":"Lakshmaiah","year":"2014"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.v107:4"},{"key":"R16","first-page":"499","article-title":"Emission Tomography: The fundamentals of PET and SPECT","author":"Morris","year":"2004"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1002\/(ISSN)1099-1344"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1685"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2008.12.005"},{"issue":"4","key":"R20","first-page":"324","article-title":"Targeting histone deacetylase in lung cancer for early diagnosis: 18F-FAHA PET\/CT imaging of NNK-treated A\/J mice model","volume":"4","author":"Tang","year":"2014"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1080\/10408360490516922"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.057174"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210599"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2012.09.019"}],"event":{"name":"SPIE Medical Imaging","location":"San Diego, California, United States"},"container-title":["SPIE Proceedings","Medical Imaging 2016: Biomedical Applications in Molecular, Structural, and Functional Imaging"],"original-title":[],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T01:40:46Z","timestamp":1538098846000},"score":1,"resource":{"primary":{"URL":"http:\/\/proceedings.spiedigitallibrary.org\/proceeding.aspx?doi=10.1117\/12.2216905"}},"subtitle":[],"editor":[{"given":"Barjor","family":"Gimi","sequence":"first","affiliation":[]},{"given":"Andrzej","family":"Krol","sequence":"additional","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2016,3,29]]},"references-count":24,"URL":"https:\/\/doi.org\/10.1117\/12.2216905","relation":{},"ISSN":["0277-786X"],"issn-type":[{"value":"0277-786X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3,29]]}}}